Chicago, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Circana, LLC today announced the launch of Liquid Testing™, an AI-powered, self-serve tool that gives consumer packaged goods and general merchandise ...

A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping some avoid further tests and treatments, including chemotherapy.

Crestchic has launched a new loadbank designed to test liquid-cooled data center infrastructure. The company, a manufacturer ...

Two abstracts on liquid biopsy tests revealed the potential of analyzing circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) in promoting heightened decision-making by clinicians for ...

Please provide your email address to receive an email when new articles are posted on . Researchers at Johns Hopkins Sidney Kimmel Cancer Center have developed an automated liquid biopsy test that can ...

As targeted therapies have grown in importance for treating cancers, the ability to detect genetic mutations that tumors carry has as well. While this often involves performing tissue biopsies, there ...

insights from industryErik GublerProduct ManagerMettler-Toledo GmbH In this interview, AZoM speaks to Erik Gubler, Product Manager at Mettler-Toledo GmbH, about e-liquid testing; how to do it, why it ...

Here we conclude our discussion with David P. Carbone, MD, PhD, The Ohio State University, by addressing the importance of both advocacy for and education on biomarker testing in the lung cancer space ...

A company developing liquid biopsy technology for the early detection of cancers has new data that it is presenting Saturday at a major cancer conference. Menlo Park, California-based Grail said it ...